Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Neutropenia and ASXL1[original query] |
|---|
| ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases. PloS one 2014 9 (1): e85362. Damaj Gandhi, Joris Magalie, Chandesris Olivia, Hanssens Katia, Soucie Erinn, Canioni Danielle, Kolb Brigitte, Durieu Isabelle, Gyan Emanuel, Livideanu Cristina, Chèze Stephane, Diouf Momar, Garidi Reda, Georgin-Lavialle Sophie, Asnafi Vahid, Lhermitte Ludovic, Lavigne Christian, Launay David, Arock Michel, Lortholary Olivier, Dubreuil Patrice, Hermine Olivi |
| Genetic mutations associated with blood count abnormalities in myeloid neoplasms. Hematology (Amsterdam, Netherlands) 2022 6 27 (1): 765-771. Polprasert Chantana, Kongkiatkamon Sunisa, Niparuck Pimjai, Rattanathammethee Thanawat, Wudhikarn Kitsada, Chuncharunee Suporn, Kobbuaklee Sirorat, Suksusut Amornchai, Lanamtieng Theerin, Lawasut Panisinee, Asawapanumas Thiti, Bunworasate Udomsak, Rojnuckarin Ponlap |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. Frontiers in oncology 2022 4 12 795955. Fattizzo Bruno, Levati Giorgia Virginia, Giannotta Juri Alessandro, Cassanello Giulio, Cro Lilla Marcella, Zaninoni Anna, Barbieri Marzia, Croci Giorgio Alberto, Revelli Nicoletta, Barcellini Wil |
| [Clinical characteristics of myeloid tumors combined with the proliferation of large granular lymphocytes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2024 7 45 (4): 396-400. C X Du, G P Xiang, L Peng, X Y Xiao, G S Teng, Y H Zhang, Y Wang, Y F Duan, Z H Shao, J B |
- Page last reviewed:Feb 1, 2024
- Content source: